Child-resistant packaging
This article was originally published in The Rose Sheet
Executive Summary
Topical OTC drugs are not included in Consumer Product Safety Commission's notice of proposed rulemaking requiring child-resistant packaging for Rx-to-OTC switch drug products published in the Federal Register Aug. 30. The rule would apply only to switched oral drug products, including certain antihistamine active ingredients. CPSC also is proposing to reverse a requirement that companies wait until FDA approves an OTC switch before applying for a CRP exemption. Comments are due Nov. 13